You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

Article metrics

Article menu

Download PDFPDF

Coronary artery disease
Original research article
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

 

Online download statistics by month:

Online download statistics by month: September 2018 to January 2021

AbstractFullPdf
Sep 201811311425
Oct 201819619535
Nov 2018697025
Dec 2018525224
Jan 2019575621
Feb 2019494914
Mar 2019474616
Apr 2019464514
May 2019323217
Jun 201927266
Jul 2019303016
Aug 201923236
Sep 201924242
Oct 201936367
Nov 201919195
Dec 201926257
Jan 2020242411
Feb 202041391
Mar 202030309
Apr 202018188
May 202020207
Jun 202030309
Jul 202024246
Aug 202013133
Sep 2020413815
Oct 202023215
Nov 202028278
Dec 202029297
Jan 2021454217
Total12121197346